null

Uliledlimab (Anti-CD73) Biosimilar Antibody

SKU:
HDBS0107
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CD73
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€373
Frequently bought together:

Description

system_update_altDatasheet

Uliledlimab (Anti-CD73) Biosimilar Antibody (HDBS0107)

The ULILEDlimab Biosimilar Anti-CD73 Antibody is a cutting-edge tool for researchers investigating the role of CD73, an important cell surface enzyme involved in immune regulation and cancer progression. This antibody, developed as a biosimilar to the well-known anti-CD73 antibody ULILED, has been optimized for maximum specificity and sensitivity in binding to the CD73 protein in human samples.By targeting CD73, researchers can explore its functions in immune suppression, adenosine production, and tumor microenvironment modulation. The ULILEDlimab Biosimilar Anti-CD73 Antibody is ideal for use in Western blotting, immunohistochemistry, and flow cytometry applications, allowing for comprehensive analysis of CD73 expression and localization in various cell types and tissues.

With its high reactivity and validation for specific research applications, this antibody is a valuable tool for studies in immunology, oncology, and drug development. Understanding the mechanisms of CD73 activity and its role in disease pathology is essential for developing targeted therapies against cancer, inflammatory disorders, and other conditions where CD73 dysregulation plays a significant role.